126 related articles for article (PubMed ID: 12548588)
1. Bone cancer pain.
Clohisy DR; Mantyh PW
Cancer; 2003 Feb; 97(3 Suppl):866-73. PubMed ID: 12548588
[TBL] [Abstract][Full Text] [Related]
2. Bone cancer pain.
Clohisy DR; Mantyh PW
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S279-88. PubMed ID: 14600620
[TBL] [Abstract][Full Text] [Related]
3. Osteoprotegerin diminishes advanced bone cancer pain.
Luger NM; Honore P; Sabino MA; Schwei MJ; Rogers SD; Mach DB; Clohisy DR; Mantyh PW
Cancer Res; 2001 May; 61(10):4038-47. PubMed ID: 11358823
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.
Sabino MA; Ghilardi JR; Jongen JL; Keyser CP; Luger NM; Mach DB; Peters CM; Rogers SD; Schwei MJ; de Felipe C; Mantyh PW
Cancer Res; 2002 Dec; 62(24):7343-9. PubMed ID: 12499278
[TBL] [Abstract][Full Text] [Related]
5. Endothelin and the tumorigenic component of bone cancer pain.
Peters CM; Lindsay TH; Pomonis JD; Luger NM; Ghilardi JR; Sevcik MA; Mantyh PW
Neuroscience; 2004; 126(4):1043-52. PubMed ID: 15207337
[TBL] [Abstract][Full Text] [Related]
6. Alteration of cancer pain-related signals by radiation: proteomic analysis in an animal model with cancer bone invasion.
Park HC; Seong J; An JH; Kim J; Kim UJ; Lee BW
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1523-34. PubMed ID: 15817359
[TBL] [Abstract][Full Text] [Related]
7. Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain.
Furuse S; Kawamata T; Yamamoto J; Niiyama Y; Omote K; Watanabe M; Namiki A
Anesthesiology; 2009 Jul; 111(1):173-86. PubMed ID: 19512863
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord.
Honore P; Luger NM; Sabino MA; Schwei MJ; Rogers SD; Mach DB; O'keefe PF; Ramnaraine ML; Clohisy DR; Mantyh PW
Nat Med; 2000 May; 6(5):521-8. PubMed ID: 10802707
[TBL] [Abstract][Full Text] [Related]
9. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization.
Sevcik MA; Ghilardi JR; Peters CM; Lindsay TH; Halvorson KG; Jonas BM; Kubota K; Kuskowski MA; Boustany L; Shelton DL; Mantyh PW
Pain; 2005 May; 115(1-2):128-41. PubMed ID: 15836976
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced alteration of pain-related signals in an animal model with bone invasion from cancer.
Seong J; Park HC; Kim J; Kim UJ; Lee BW
Ann N Y Acad Sci; 2004 Dec; 1030():179-86. PubMed ID: 15659796
[TBL] [Abstract][Full Text] [Related]
11. Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer.
Halvorson KG; Sevcik MA; Ghilardi JR; Rosol TJ; Mantyh PW
Clin J Pain; 2006 Sep; 22(7):587-600. PubMed ID: 16926574
[TBL] [Abstract][Full Text] [Related]
12. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons.
Niiyama Y; Kawamata T; Yamamoto J; Omote K; Namiki A
Neuroscience; 2007 Aug; 148(2):560-72. PubMed ID: 17656027
[TBL] [Abstract][Full Text] [Related]
13. Advances in understanding bone cancer pain.
Goblirsch MJ; Zwolak P; Clohisy DR
J Cell Biochem; 2005 Nov; 96(4):682-8. PubMed ID: 16149079
[TBL] [Abstract][Full Text] [Related]
14. [Progress in the basic research on neurobiological mechanisms of cancer pain].
Zhang Y; Han JS; Wang Y
Sheng Li Ke Xue Jin Zhan; 2004 Jul; 35(3):224-8. PubMed ID: 15469092
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain.
Peters CM; Ghilardi JR; Keyser CP; Kubota K; Lindsay TH; Luger NM; Mach DB; Schwei MJ; Sevcik MA; Mantyh PW
Exp Neurol; 2005 May; 193(1):85-100. PubMed ID: 15817267
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of pain-related behavior, bone destruction and effectiveness of fentanyl, sufentanil, and morphine in a murine model of cancer pain.
El Mouedden M; Meert TF
Pharmacol Biochem Behav; 2005 Sep; 82(1):109-19. PubMed ID: 16125759
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain.
Hald A; Nedergaard S; Hansen RR; Ding M; Heegaard AM
Eur J Pain; 2009 Feb; 13(2):138-45. PubMed ID: 18499488
[TBL] [Abstract][Full Text] [Related]
18. A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone.
Halvorson KG; Kubota K; Sevcik MA; Lindsay TH; Sotillo JE; Ghilardi JR; Rosol TJ; Boustany L; Shelton DL; Mantyh PW
Cancer Res; 2005 Oct; 65(20):9426-35. PubMed ID: 16230406
[TBL] [Abstract][Full Text] [Related]
19. A mechanism-based understanding of bone cancer pain.
Mantyh PW
Novartis Found Symp; 2004; 261():194-214; discussion 214-9, 256-61. PubMed ID: 15469052
[TBL] [Abstract][Full Text] [Related]
20. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia.
Zhang RX; Liu B; Wang L; Ren K; Qiao JT; Berman BM; Lao L
Pain; 2005 Nov; 118(1-2):125-36. PubMed ID: 16154703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
